Li Chen, Liu Ao-Fei, Qiu Han-Cheng, Lv Xianli, Zhou Ji, Zhang Yi-Qun, Lv Jin, Zhang Ying-Ying, Hu Sushan, Liu Fang, Liu Yun-E, Jin Min, Jiang Wei-Jian
New Era Stroke Care and Research Institute, PLA Rocket Force Characteristic Medical Center, 18 Xinjiekouwai Street, Beijing, 100088, China.
Neurosurgery Department, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Chin Neurosurg J. 2021 May 2;7(1):26. doi: 10.1186/s41016-021-00243-3.
Treatment of perforator involving aneurysm (piAN) remains a challenge to open and endovascular neurosurgeons. Our aim is to demonstrate a primary outcome of endovascular therapy for piANs with the use of perforator preservation technologies (PPT) based on a new neuro-interventional classification.
The piANs were classified into type I: aneurysm really arises from perforating artery, type II: saccular aneurysm involves perforating arteries arising from its neck (IIa) or dome (IIb), and type III: fusiform aneurysm involves perforating artery. Stent protection technology of PPT was applied in type I and III aneurysms, and coil-basket protection technology in type II aneurysms. An immediate outcome of aneurysmal obliteration after treatment was evaluated (satisfactory obliteration: the saccular aneurysm body is densely embolized (I), leaving a gap in the neck (IIa) or dome (IIb) where the perforating artery arising; fusiform aneurysm is repaired and has a smooth inner wall), and successful perforating artery preservation was defined as keeping the good antegrade flow of those perforators on postoperative angiography. The periprocedural complication was closely monitored, and clinical and angiographic follow-ups were performed.
Six consecutive piANs (2 ruptured and 4 unruptured; 1 type I, 2 type IIa, 2 type IIb, and 1 type III) in 6 patients (aged from 43 to 66 years; 3 males) underwent endovascular therapy between November 2017 and July 2019. The immediate angiography after treatment showed 6 aneurysms obtained satisfactory obliteration, and all of their perforating arteries were successfully preserved. During clinical follow-up of 13-50 months, no ischemic or hemorrhagic event of the brain occurred in the 6 patients, but has one who developed ischemic event in the territory of involving perforators 4 h after operation and completely resolved within 24 h. Follow-up angiography at 3 to 10M showed patency of the parent artery and perforating arteries of treated aneurysms, with no aneurysmal recurrence.
Our perforator preservation technologies on the basis of the new neuro-interventional classification seem feasible, safe, and effective in protecting involved perforators while occluding aneurysm.
涉及动脉瘤的穿支动脉(piAN)的治疗对开放和血管内神经外科医生来说仍然是一个挑战。我们的目的是基于一种新的神经介入分类,展示使用穿支动脉保留技术(PPT)对piAN进行血管内治疗的主要结果。
piAN被分为I型:动脉瘤真正起源于穿支动脉;II型:囊状动脉瘤累及起源于其颈部(IIa)或瘤顶(IIb)的穿支动脉;III型:梭形动脉瘤累及穿支动脉。I型和III型动脉瘤应用PPT的支架保护技术,II型动脉瘤应用线圈篮保护技术。评估治疗后动脉瘤闭塞的即刻结果(满意闭塞:囊状动脉瘤体被致密栓塞(I),在起源穿支动脉的颈部(IIa)或瘤顶(IIb)留有间隙;梭形动脉瘤修复且内壁光滑),成功保留穿支动脉定义为术后血管造影显示这些穿支动脉保持良好的顺行血流。密切监测围手术期并发症,并进行临床和血管造影随访。
2017年11月至2019年7月期间,6例患者(年龄43至66岁;男性3例)的6个连续piAN(2个破裂,4个未破裂;1个I型,2个IIa型,2个IIb型,1个III型)接受了血管内治疗。治疗后的即刻血管造影显示6个动脉瘤获得满意闭塞,且所有穿支动脉均成功保留。在13至50个月的临床随访期间,6例患者均未发生脑部缺血或出血事件,但有1例在术后4小时在累及穿支动脉的区域发生缺血事件,并在24小时内完全缓解。3至10个月的随访血管造影显示治疗动脉瘤的供血动脉和穿支动脉通畅,无动脉瘤复发。
我们基于新的神经介入分类的穿支动脉保留技术在闭塞动脉瘤的同时保护受累穿支动脉方面似乎可行、安全且有效。